Merck to Buy OncoImmune for $425 Million Amid Race for Covid-19 Treatments
The drugmaker is buying biopharmaceutical company OncoImmune, which has reported positive results from a late-stage study of a coronavirus therapeutic candidate, for $425 million in cash.
AstraZeneca, Oxford Vaccine Up to 90% Effective in Trials
The success of the vaccine being developed by the University of Oxford and AstraZeneca bodes well for the near-term availability of a third treatment for Covid-19, joining those from Moderna as well as Pfizer and BioNTech.
Facebook Ads Could Be Reaching Saturation Point
Facebook has driven monster revenue growth quarter after quarter by driving up ad impressions and tinkering with prices to compensate. But that strategy may only work for so long before its users become overserved.
CoStar to Buy Homesnap for $250 Million
CoStar Group, one of the world's largest providers of commercial real-estate information and analytics, has taken its first major step into the residential data business by agreeing to pay $250 million for Homesnap.
FDA Authorizes Regeneron's Covid-19 Antibody Cocktail Drug
Regeneron's Covid-19 antibody drug is the second cleared this month to treat patients who aren't hospitalized but are at high risk of developing severe disease.
Bain Capital Raises $800 Million for Second Impact Investing Fund
Bain Capital has raised $800 million in fresh capital to back businesses that the firm bets will benefit not only fund investors but also society at large.
European Insurers Prepare for Deals
The insurers say they have weathered the crucible of the coronavirus pandemic and are ready to do some deals.
The World After Covid Could Shake Up Business Flights
A smaller, more price-sensitive corporate market is likely to become a new battleground between low-cost and legacy airlines.
Evergrande Property Services Plans $2.04 Billion Hong Kong IPO
A unit of China Evergrande Group is planning to raise up to $2.04 billion through an initial public offering in Hong Kong, the latest Chinese firm to tap the city's hot equities-fund raising market.
Walmart Heirs Back Startup Developing $10 At-Home Covid-19 Tests
The billionaire Walton family that controls the retail giant is among a group of investors in NowDiagnostics, a startup aiming to design at-home coronavirus tests to sell for as little as $10 in Walmart stores and elsewhere.
(END) Dow Jones Newswires